Mostrar el registro sencillo del ítem
dc.contributor.author | Mazagatos, Clara | |
dc.contributor.author | Monge Corella, Susana | |
dc.contributor.author | Olmedo, Carmen | |
dc.contributor.author | Vega-Piris, Lorena | |
dc.contributor.author | Gallego Berciano, Pilar | |
dc.contributor.author | Martín-Merino, Elisa | |
dc.contributor.author | Sierra, María José | |
dc.contributor.author | Limia, Aurora | |
dc.contributor.author | Larrauri, Amparo | |
dc.contributor.author | Working Group for the surveillance and control of COVID-19 in Spain | |
dc.date.accessioned | 2022-04-07T09:24:19Z | |
dc.date.available | 2022-04-07T09:24:19Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Euro Surveill. 2021;26(24). | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/13943 | |
dc.description.abstract | Residents in long-term care facilities (LTCF) experienced a large morbidity and mortality during the COVID-19 pandemic in Spain and were prioritised for early COVID-19 vaccination. We used the screening method and population-based data sources to obtain estimates of mRNA COVID-19 vaccine effectiveness for elderly LTCF residents. The estimates were 71% (95% CI: 56-82%), 88% (95% CI: 75-95%), and 97% (95% CI: 92-99%), against SARS-CoV-2 infections (symptomatic and asymptomatic), and COVID-19 hospitalisations and deaths, respectively. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | European Centre for Disease Prevention and Control (ECDC) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | COVID-19 | es_ES |
dc.subject | LTCF | es_ES |
dc.subject | Screening | es_ES |
dc.subject | Surveillance | es_ES |
dc.subject | Vaccination | es_ES |
dc.subject.mesh | COVID-19 | es_ES |
dc.subject.mesh | COVID-19 Vaccines | es_ES |
dc.subject.mesh | Aged | es_ES |
dc.subject.mesh | Hospitalization | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Long-Term Care | es_ES |
dc.subject.mesh | Pandemics | es_ES |
dc.subject.mesh | RNA, Messenger | es_ES |
dc.subject.mesh | SARS-CoV-2 | es_ES |
dc.subject.mesh | Spain | es_ES |
dc.title | Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021 | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 34142647 | es_ES |
dc.format.volume | 26 | es_ES |
dc.format.number | 24 | es_ES |
dc.identifier.doi | 10.2807/1560-7917.ES.2021.26.24.2100452 | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1560-7917 | es_ES |
dc.relation.publisherversion | https://doi.org/10.2807/1560-7917.ES.2021.26.24.2100452 | es_ES |
dc.identifier.journal | Euro Surveillance | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Epidemiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |